- First completely redesigned mammography platform in over a decade
- PlatinumTomo 3D equipped with new tube technology, detector and AI technology
- New features reduce patient discomfort and improve user ergonomics
Siemens Healthineers is pleased to announce MAMMOMAT B.brilliant, the company's first completely redesigned mammography platform in more than a decade, has received Health Canada licensing. This innovative system with wide-angle tomosynthesis offers significant advancements in image quality, user ergonomics, and patient comfort level.
“We are excited to bring MAMMOMAT B.brilliant to Canada to offer more accurate, faster and conclusive breast cancer screenings for women to exclude the maybes,” says Peter Vidic, X-ray Business Line Manager at Siemens Healthineers, Canada “Experience a completely new system design that is focused entirely on the patient and the mammographer,” he added.
Revolutionary mammography imaging technology
PlatinumTomo, the new 3D technology will acquire the tomosynthesis volume at the same angular range of 50°—the widest angle on the market—as the company’s current system, the MAMMOMAT Revelation, for a high level of depth resolution and tissue separation. The 3D portion will feature completely new acquisition technology, with a new detector and a new X-ray tube design based on the premium z-sharp (flying focal spot) technology found on the company’s computed tomography scanners. The flying focal spot technology is designed to allow for continuous tube motion, while holding the focal spot size effectively stable. UltraHD reconstruction technology will provide customizable image impression as well as a new form of synthetic 2D and 3D imaging.
Enhanced patient comfort and user experience with design around the individual woman
MAMMOMAT B.brilliant, with a scan time of around five seconds, is the fastest wide-angle tomosynthesis on the market, creating a 3D image with high-depth resolution in the shortest time possible. It offers a 35% faster acquisition speed compared to other devices, making the examination more comfortable for patients. The ComfortPackage, which is standard on the system, includes an ergonomic hand grip and an optimized, stationary face shield that allows the patient to lean into the system during image acquisition for greater stability and ease of positioning. These new features are combined with a redesigned ambient light display, personalized soft breast compression, and curved breast compression paddles. These features can not only reduce patient discomfort but also improve breast positioning and enable more consistent image quality.
Advanced radiologic technologist ergonomics and workflow
Several new features benefit the radiologic technologist. They include a prominent display monitor that enables the technologist to clearly see patient information and work steps, regardless of where the technologist is positioned. The automated ComfortMove ergonomic feature reduces physical strain on the technologist, who can move the tube head independently of the bucky for safe, easy patient access during positioning without bending or twisting. A laser positioning guide helps the technologist accurately position the patient’s breast. Together, these user features can significantly improve workflow.
Commitment to Women's Health
"With the licensing of the MAMMOMAT B.brilliant, Siemens Healthineers is proud to bring this next-generation mammography technology to Canada," said Melissa Reeve, Women Health Clinical Product Specialist. " Our commitment to women's health is unwavering, and we believe in providing access to the most advanced screenings and diagnostics available."
For more information on MAMMOMAT B.brilliant, please visit www.siemens-healthineers.com/en-ca/mammomat-bbrilliant
About Siemens Healthineers:
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com.